Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks – Healio
Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks Healiosource
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes – Abbott MediaRoom
Abbott’s Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes Abbott MediaRoomsource
UW study: Could targeting neurons in the brain help treat type 2 diabetes? – KIRO 7 News Seattle
UW study: Could targeting neurons in the brain help treat type 2 diabetes? KIRO 7 News Seattlesource